'%3e%3cpath%20fill='%23ffffff'%20d='M%20226.007812%20574.207031%20C%20153%20574.207031%2093.871094%20633.339844%2093.871094%20706.34375%20C%2093.871094%20779.347656%20153%20838.476562%20226.007812%20838.476562%20C%20299.011719%20838.476562%20358.140625%20779.347656%20358.140625%20706.34375%20C%20358.140625%20633.339844%20299.011719%20574.207031%20226.007812%20574.207031%20Z%20M%20226.007812%20574.207031%20'%20fill-opacity='1'%20fill-rule='nonzero'/%3e%3c/g%3e%3cg%20clip-path='url(%23c259d1be04)'%3e%3cpath%20fill='%23ffffff'%20d='M%20936.96875%20115.105469%20C%20863.964844%20115.105469%20804.835938%20174.234375%20804.835938%20247.238281%20C%20804.835938%20320.242188%20863.964844%20379.375%20936.96875%20379.375%20C%201009.972656%20379.375%201069.105469%20320.242188%201069.105469%20247.238281%20C%201069.105469%20174.234375%201009.972656%20115.105469%20936.96875%20115.105469%20Z%20M%20936.96875%20115.105469%20'%20fill-opacity='1'%20fill-rule='nonzero'/%3e%3c/g%3e%3cg%20clip-path='url(%23352427e82d)'%3e%3cpath%20fill='%23ffffff'%20d='M%201189.242188%201157.730469%20C%201116.238281%201157.730469%201057.105469%201216.863281%201057.105469%201289.867188%20C%201057.105469%201362.871094%201116.238281%201422%201189.242188%201422%20C%201262.246094%201422%201321.375%201362.871094%201321.375%201289.867188%20C%201321.375%201216.863281%201262.246094%201157.730469%201189.242188%201157.730469%20Z%20M%201189.242188%201157.730469%20'%20fill-opacity='1'%20fill-rule='nonzero'/%3e%3c/g%3e%3cg%20clip-path='url(%23f67a3a7a20)'%3e%3cpath%20fill='%23ffffff'%20d='M%20756.414062%20511.328125%20C%20622.160156%20511.328125%20513.425781%20620.066406%20513.425781%20754.316406%20C%20513.425781%20888.566406%20622.160156%20997.304688%20756.414062%20997.304688%20C%20890.664062%20997.304688%20999.402344%20888.566406%20999.402344%20754.316406%20C%20999.402344%20620.066406%20890.664062%20511.328125%20756.414062%20511.328125%20Z%20M%20756.414062%20511.328125%20'%20fill-opacity='1'%20fill-rule='nonzero'/%3e%3c/g%3e%3cpath%20stroke-linecap='butt'%20transform='matrix(0.75,%200,%200,%200.75,%20226.007095,%20719.067518)'%20fill='none'%20stroke-linejoin='miter'%20d='M%200.000957089%2014.998519%20L%20640.001012%2014.998519%20'%20stroke='%23ffffff'%20stroke-width='30'%20stroke-opacity='1'%20stroke-miterlimit='4'/%3e%3cpath%20stroke-linecap='butt'%20transform='matrix(0.220142,%20-0.716964,%200.716964,%200.220142,%20822.082523,%20526.918183)'%20fill='none'%20stroke-linejoin='miter'%20d='M%200.00159185%2014.998056%20L%20248.679965%2015.000052%20'%20stroke='%23ffffff'%20stroke-width='30'%20stroke-opacity='1'%20stroke-miterlimit='4'/%3e%3cpath%20stroke-linecap='butt'%20transform='matrix(-0.501722,%20-0.557472,%200.557472,%20-0.501722,%201129.821968,%201216.754515)'%20fill='none'%20stroke-linejoin='miter'%20d='M%20-0.00137282%2014.997961%20L%20608.594779%2015.002501%20'%20stroke='%23ffffff'%20stroke-width='30'%20stroke-opacity='1'%20stroke-miterlimit='4'/%3e%3c/svg%3e)
Media
Search Releases
Type keywords to filter the list of press releases:
Press Releases
Loading…
Video Interviews
PharmAla Biotech — Company Overview
An introduction to PharmAla's clinical-grade MDMA program.
CEO Interview — The Future of MDMA Therapy
Nicholas Kadysh discusses the path forward for MDMA-assisted therapy.
Psychedelics Canada Panel
PharmAla leadership joins industry peers on the state of the Canadian psychedelic sector.
Investor Webinar Q4 2024
Quarterly investor update and pipeline review.